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Abstract
Research on influenza viruses regarding transmission and survival has surged in the recent years 
due to infectious emerging strains and outbreaks such as the 2009 Influenza A (H1N1) pandemic. 
MS2 coliphage has been applied as a surrogate for pathogenic respiratory viruses, such as 
influenza, as it’s safe for personnel to handle and requires less time and labor to measure virus 
infectivity. However, direct comparisons to determine the effectiveness of coliphage as a surrogate 
for influenza virus regarding droplet persistence on personal protective equipment such as N95 
filtering facepiece respirators (FFRs) are lacking. Persistence of viral droplets deposited on FFRs 
in healthcare settings is important to discern due to the potential risk of infection via indirect 
fomite transmission. The objective of this study was to determine if MS2 coliphage could be 
applied as a surrogate for influenza A viruses for studying persistence when applied to the FFRs as 
a droplet. The persistence of MS2 coliphage and 2009 Pandemic Influenza A (H1N1) Virus on 
FFR coupons in different matrices (viral media, 2% fetal bovine serum, and 5 mg ml−1 mucin) 
were compared over time (4, 12, 24, 48, 72, and 144 hours) in typical absolute humidity 
conditions (4.1 × 105 mPa [18°C/20% relative humidity (RH)]). Data revealed significant 
differences in viral infectivity over the 6-day period (H1N1- P <0.0001; MS2 - P <0.005), 
although a significant correlation of viral log10 reduction in 2% FBS (P <0.01) was illustrated. 
Overall, MS2 coliphage was not determined to be a sufficient surrogate for influenza A virus with 
respect to droplet persistence when applied to the N95 FFR as a droplet.
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Personal protective equipment (PPE) serves as the last line of defense in the hierarchy of 
protective measures for healthcare workers (HCWs) treating patients with influenza. For 
respiratory protection, the CDC recommends N95 filtering facepiece respirators (FFRs) for 
HCWs during aerosol generating procedures performed on patients with seasonal influenza 
and often recommends the use of FFRs for treating patients with novel respiratory pathogens 
such as 2009 Influenza A (H1N1; CDC 2013). Influenza virus transmission routes continue 
to be a point of discussion and fomite transmission in healthcare settings is an important 
route to consider. It’s particularly important for HCWs to follow these guidelines in addition 
to proper infection control procedures (e.g. hand hygiene) as they attend their patients due to 
the potential transmission pathways for influenza and other infectious agents. Although 
direct scientific evidence is lacking, FFRs used by HCWs for respiratory protection can 
potentially serve as a source of infectious pathogens if contaminated by spreading from the 
FFR to the wearer and others via indirect contact. For routine single use, where the FFRs are 
immediately disposed after one patient encounter, contact transfer of pathogens should not 
occur if the wearer complies with proper FFR use guidance, which states that the hands of 
the HCW should never come in contact with the contaminated surface of the FFR. Correctly 
removing or ‘doffing’ an FFR, requires the wearer to grab the straps of the FFR located at 
the back of the head and avoid touching the surface (CDC). However, studies evaluating 
HCWs respiratory or PPE protection programs observed differing rates of correctly doffing 
respirators (7.2% in California hospitals during the 2009–2010 H1N1 influenza pandemic - 
Beckman et al. 2013; 62.5% in New York State hospitals - Hines et al. 2013) or masks (72% 
in Canadian acute care hospitals - Mitchell et al. 2013). Two of these studies incorporated 
hand hygiene observations and the percentage of HCWs that conducted proper hand hygiene 
after removing the PPE were comparatively low (47.1% - Beckman et al. 2013; 43% - 
Mitchell et al. 2013). An additional study from Canada during the 2003 SARS outbreak 
showed 35% of HCWs were not using proper hand hygiene after removing their protection, 
while hand hygiene may have been conducted before the removal (Raboud et al. 2010). It’s 
reasonable to ascertain that contact transfer from facemask, including FFRs, is possible; 
however the risks associated with the contact transmission depends on many factors 
including pathogen contamination levels and persistence.
Although transmission of infectious respiratory viruses on FFRs used during healthcare 
practices is currently unknown, Coulliette et al. 2013 revealed that influenza A (H1N1) 
viruses may remain infectious for at least six days on a N95 FFR. While this study directly 
measured infectious influenza A virus, numerous studies have used surrogates for 
respiratory viruses due to the technical skills required, costly infectivity detection methods 
and biosafety risks involved with handling human respiratory viruses. MS2 coliphage, a 
male-specific coliphage specific to Escherichia coli, has been consistently used as a 
surrogate for respiratory viruses. For example, MS2 coliphage has been applied as a 
surrogate for airborne human pathogenic viruses, referring to influenza virus as a common 
discussion point, for the development of aerosol chambers (Woo et al. 2010), examination of 
re-aerosolization from N95 FFRs during simulated coughs (Fisher et al. 2012), comparison 
of disinfection approaches for FFRs (Vo et al. 2009, Rengasamy et al. 2010, Damit et al. 
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2011, Fisher et al. 2011a, and Fisher et al. 2011b), measurement of hospital air handling 
systems (Griffiths et al. 2005), and disinfection techniques for airborne viruses (Walker and 
Ko 2007). Additional studies focused on enteric and respiratory pathogens regarding fomite 
transfer (Lopez et al. 2013), surface survival and persistence (Liu et al. 2012), sodium 
hyphochlorite disinfection on stainless steel (Park and Sobsey 2011), fomite transfer from 
fingerpads (Julian et al. 2010), and efficacy of hand hygiene agents (Sickbert-Bennett et al. 
2005) have also incorporated MS2 coliphage as a surrogate. The reliance on MS2 coliphage 
as a surrogate for respiratory pathogens in research aiming to examine PPE, engineering 
controls and recommendations for protective measures (e.g. respirator reuse, aerosolization 
of viruses from respirators, hospital air handling systems, fomite transfer via health 
practitioner hands) could impact public health decisions based upon interpretations of such 
data for exposure and risk values in healthcare settings.
To determine if MS2 coliphage could be applied to FFRs as droplets as a surrogate for 
influenza A viruses for droplet persistence, MS2 coliphage and the 2009 Pandemic Influenza 
A (H1N1) Virus (pH1N1) were simultaneously measured and compared on N95 FFRs at a 
typical indoor absolute humidity (AH) of 4.1 × 105 mPa [18°C/20% relative humidity (RH)] 
over a 6-day period in different matrices. Our null hypothesis was that there would be no 
difference or correlation in persistence between MS2 coliphage and pH1N1 or impact of 
different matrices on these parameters. Similar correlation in persistence levels would allow 
MS2 coliphage to be appropriately applied as a surrogate for influenza virus studies.
METHODS AND MATERIALS
The experimental design, including pH1N1 viral propagation and infectivity method, test 
matrices preparation, N95 FFR coupon creation, AH conditions and calculations, sample 
processing, ELISA, and data analysis are all fully described in Coulliette et al. 2013. Briefly, 
pH1N1 [(Influenza A/ California/04/2009 H1N1 (influenza A [pH1N1])] and MS2 
coliphage (ATCC 15597-B1) were combined equally with the sample matrices of viral 
media (Dulbecco’s modified Eagle media [DMEM]), 2% fetal bovine serum (FBS; Atlanta 
Biologicals, Lawrenceville, GA), and 5 mg ml−1 mucin (BP Biomedicals, Soloni, OH), 
deposited one liquid droplet (100 µl) onto N95 FFR (3M model no. 8210) coupons (3.8 to 
4.2 cm2) using a cell spreader to evenly distribute the solution, allowed the droplet to air dry 
for 1 hour (BSC sash closed and blower off), placed in an environmental chamber (model 
no. 6030; Carion, Marietta, OH) at an AH of 4.1 × 105 mPa and removed for viral testing at 
time-points 0, 4, 12, 24, 48, 72, and 144 hours. The conditions of the study at 4.1 × 105 mPa 
[18°C/20% relative humidity (RH)] simulate typical indoor conditions. To recover pH1N1 
and MS2 coliphage from the coupons, the coupons were placed in 5 ml of 2% BSA-1X PBS 
(pH 8.5) and subjected to the following steps to purify the sample: vortex − 20 min, 
centrifugation − 5 min at 3,000× g, filtration - premoistened (2% BSA-1X PBS) 0.22 m 
syringe filter (Fisherbrand, Pittsburgh, PA, Millex-GS, Billerica, MA). This recovery 
method was compared to other processed and determined to yield the highest recovery (data 
not shown). Some loss may have occurred during the recovery step, as Li et al. (2009) 
showed approximately one-half log10 loss for MS2 coliphage and nanofiber filters. 
However, in this study, viral concentrations were measured for time-point zero after this 
recovery process, were at high enough concentrations to measure reduction over the six 
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days, and the authors assumed negligible loss from the vortex step. Persistence of pH1N1 
was quantified by using an enzyme-linked immunosorbent assay (ELISA) to determine the 
log10 tissue culture infectious dose of 50% (TCID50) per coupon as previously described 
(Coulliette et al. 2013), while MS2 coliphage was enumerated by single agar layer plaque 
assay using E. coli (ATCC 15597) as previously described (EPA 2001), using ATCC media 
for propagating and plating (Fisher et al. 2009). For each plate, the plaque forming units 
(PFU) were counted and only values between 30 and 300 PFU were recorded. The 
experiment was repeated three times (n=3) and triplicate samples were processed for each 
method. Generalized Estimating Equations (GEE) was used to account for potential 
correlation within replicates. Descriptive statistics were conducted using Microsoft Excel 
v14 (Redmond, WA), while statistical analyses for Spearman coefficients, maximum 
likelihood estimates (MLEs), and GEE- were processed using SAS 9.3 (Cary, NC). The 
significance level was set at a P ≤ 0.01.
RESULTS
The average starting inoculum for pH1N1 and MS2 coliphage across all matrices was 8.28 × 
103 log10 TCID50 (±5.69 × 103) and 1.44 × 1010 PFU per coupon (±2.04 × 1010), 
respectively. The initial recovery concentration (time 0) from the N95 FFR coupons for 
pH1N1 and MS2 coliphage across all matrices was 3.23 × 101 log10 TCID50 (±2.33 × 101; 
0.39% recovery) and 5.72 × 108 PFU (±6.74 × 108; 3.98% recovery) per coupon, 
respectively.
The mean log10 change in viral media from the initial concentration to the final time-point 
(144 hr) was −1.33 for pH1N1 and −1.28 for MS2 coliphage. The viruses showed a weak 
correlation in viral media (0.30, P=0.04; Table I). The mean log10 change in 2% FBS from 
the initial concentration to the final timepoint (144 hr) was −0.48 for pH1N1 and −0.35 for 
MS2 coliphage. The viruses showed a significant positive correlation across time-points in 
2% FBS (0.44, P <0.01; Table I). The mean log10 change of infectious virus in mucin (5 mg 
ml−1) from the initial concentration to the final time-point (72 hr) was −0.59 for pH1N1 and 
to the final time-point (144 hr) −0.18 for MS2 coliphage. No association was demonstrated 
in mucin (0.18, P=0.32; Table I). Generally, greater reduction in the mean log10 change per 
coupon of infectious virus over time was determined for pH1N1 in all matrices and for MS2 
coliphage in viral media, while minimal or variable reduction was seen for MS2 coliphage in 
2% FBS and artificial mucus (Table I).
Univariate analysis (MLE) revealed that time was not significantly associated with the 
persistence of either virus (P >0.01), and thereby was not included in the multivariate 
analysis (data not shown). The GEE analysis within this study simultaneously evaluated 
pH1N1 and MS2 coliphage with the matrices, which demonstrated a significant difference in 
estimated log10 change of remaining infectious pH1N1 (−0.61, P <0.0001) and MS2 
coliphage (0.25, P <0.005) viruses (Table 2; ‘Estimated standard error (SE)’ column). The 
matrices, viral media and 2% FBS, also contributed significantly to virus persistence 
characteristics (Table 2; viral media, P <0.0001; 2% FBS, P <0.01). Viral media was 
responsible for −0.61 log10 change, while 2% FBS contributed to 0.40 log10 change when all 
the model parameters are considered (Table 2; ‘Estimated (SE)’ column). The cumulative 
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log10 change can be interpreted from the GEE estimates for developing scenarios and 
revealed that the lowest persistence was observed from pH1N1 in viral media with −1.22 
log10 TCID50 per coupon (sum of pH1N1, −0.61, and viral media, −0.61, cumulative log10 
change parameter estimates). MS2 coliphage in 2% FBS showed the best persistence with 
0.04 log10 PFU per coupon (sum of the intercept, −0.61, and estimated SE for MS2, 0.25, 
and 2% FBS, 0.40).
DISCUSSION
The Recent aerosol studies have acknowledged the limitations of MS2 coliphage as a 
surrogate for human and animal respiratory viruses due to different viral behaviors (Turgeon 
et al. 2014, Zuo et al. 2013b). Noting that our study examined porous surface survival, not 
viral aerosols, our findings are in agreement as the analysis for this study reveals that 
pH1N1 and MS2 coliphage infectivity characteristics were significantly different in the 
tested conditions on N95 FFRs. The significant difference is likely attributed to pH1N1 
being an enveloped virus and MS2 coliphage being a non-enveloped virus. The authors also 
acknowledge that viruses of the Cystoviridae family (e.g. Φ−6), which are enveloped but 
consist of segmented double-stranded RNA, have been shown as an adequate influenza virus 
surrogate regarding virus aerosol models (Turgeon et al. 2014), water survival and chlorine 
disinfection (Adcock et al. 2009), and thermal inactivation through composting (Elving et al. 
2012). However, MS2 coliphage is still used in environmental microbiology research as an 
influenza surrogate due to (1) being readily available, (2) the coliphage being a safer, non-
pathogenic microorganism (Griffiths et al. 2005), and (3) requiring only a BSL-I facility 
(Woo et al. 2010); thereby becoming a default influenza virus surrogate during the 
heightened awareness of potential influenza A virus (H1N1) transmission in healthcare 
settings. While using MS2 coliphage alone as a surrogate for influenza A virus for studies 
regarding infectivity, persistence, or viral behaviors is not recommended, using MS2 
coliphage as a viral tracer for physical determinations (e.g. fomite transfer, measuring 
filtration, re-aerosolization, etc.) may be appropriate.
This concise viral comparison also provides valuable insight regarding methodology and 
persistence of MS2 coliphage and pH1N1 on N95 FFRs, a porous surface material. The 
authors recognize the limitations but being transparent can assist in future research. The 
differences in starting concentrations were an intrinsic result of differing propagating 
techniques that the authors were limited to using. While there was approximately 6 log10 
difference between pH1N1 and MS2 coliphage inoculum, the viruses were well mixed to 
create a homogenous sample with the matrix. The inoculum concentration differences could 
have played a role in the higher persistence of the MS2 coliphage virus. In addition, the 
recoveries of the viruses (0.39% to 2.65%) were lower as compared to other studies 
extracting avian influenza (approximately 20% to 80%) from similar polypropylene 
respirator materials after spike tests (Zuo et al. 2013a). It is unclear whether the 
methodologies for distributing influenza viruses were similar between studies, as the 
presented study used cell spreaders to evenly distribute the virus on the coupons and the 
coupons were not processed for time-point zero until the coupons were visibly dry. While 
other studies have recovered influenza viruses from various materials, the efficiency of 
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recovery was not mentioned and future work to determine the most efficient method for 
recovering influenza from hospital PPE would be a significant contribution to this field.
Future surface survival and fomite transmission studies should incorporate several types of 
bacteriophages, such as non-enveloped MS2 coliphage to relate to previously conducted 
research and enveloped bacteriophages from the Cystoviridae family (e.g. Φ−6). There is a 
need for this type of evaluation of various hospital surfaces and PPE, porous and non-
porous, as well as the potential transmission routes relative to influenza and other 
pathogenic viruses. Such research will identify adequate surrogates, or at least outline the 
limitations of the chosen surrogate. Overall, the authors recommend that a direct comparison 
between the pathogenic virus and surrogate should be conducted before relying on the 
surrogate as a model; and especially when calculating risk or making public health decisions 
based upon the surrogate data.
CONCLUSIONS
This study revealed significant differences in viral infectivity over the 6-day period (H1N1- 
P <0.0001; MS2 - P <0.005), although a significant correlation of viral log10 reduction in 
2% FBS (P <0.01) was illustrated. Overall, MS2 coliphage was not determined to be a 
sufficient surrogate for influenza A virus with respect to droplet persistence when applied to 
the N95 FFR as a droplet.
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Table I
Concentration (standard deviation, SD) of 2009 Pandemic Influenza A H1N1 (pH1N1; TCID50/coupon) and 
MS2 Coliphage (PFU/coupon) on N95 FFR Coupons, as well as Mean Log10 Change per Coupon Relative to 
the Zero (0 h) Time-Point in (a) Viral Media, (b) 2% FBS and (c) Mucin (5 mg ml−1), where each Value 
Represents n=9 except for 144 h (n=3). The Spearman Coefficients for pH1N1 and MS2 Coliphage within 
each Sample Matrix Are Noted as well.
(a) Viral Media (correlation: 0.30, P=0.04)
Time-point (h) Concentration Mean log10 change
pH1N1 TCID50/coupon (SD)
0 5.93 × 101 (1.79 × 101) ---
4 4.83 × 101 (1.36 × 101) −0.09
12 3.32 × 101 (3.07 × 101) −0.25
24 1.23 × 101 (4.21 × 100) −0.68
48 6.13 × 101 (8.67 × 101) 0.01
72 1.18 × 101 (6.10 × 100) −0.70
144 2.79 × 100 (2.09 × 100) −1.33
MS2 coliphage PFU/coupon (SD)
0 9.15 × 108 (±1.10 × 109) ---
4 2.29 × 108 (±3.62 × 108) −0.60
12 1.54 × 108 (±2.16 × 108) −0.77
24 3.69 × 108 (±5.64 × 108) −0.39
48 3.97 × 108 (±5.61 × 108) −0.36
72 6.23 × 108 (±9.12 × 108) −0.17
144 4.79 × 107 (±3.70 × 106) 1.28
(b) 2% FBS (correlation: 0.44, P <0.01)
Time-point (h) Concentration Mean log10 change
pH1N1 TCID50/coupon (SD)
0 2.60 × 101 (6.69 × 100) ---
4 2.29 × 101 (6.27 × 100) −0.06
12 1.45 × 101 (3.09 × 100) −0.25
24 1.24 × 101 (1.38 × 100) −0.32
48 1.36 × 101 (6.51 × 100) −0.28
72 7.40 × 100 (1.74 × 100) −0.55
144 8.66 × 100 (6.00 × 100) −0.48
MS2 coliphage PFU/coupon (SD)
0 3.21 × 108 (3.41 × 108)
4 2.49 × 108 (2.52 × 108) −0.11
12 3.49 × 108 (3.59 × 108) 0.04
24 4.06 × 108 (5.92 × 108) 0.10
48 5.06 × 108 (5.55 × 108) 0.20
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72 3.05 × 108 (2.76 × 108) −0.02
144 1.42 × 108 (8.99 × 107) −0.35
(c) Mucin (5 mg ml−1; correlation: 0.18, P=0.32)
Time-point (h) Concentration Mean log10 change
pH1N1 TCID50/coupon (SD)
0 1.15 × 101 (1.53 × 100) ---
4 8.43 × 100 (4.17 × 100) −0.13
12 7.73 × 100 (4.84 × 100) −0.17
24 2.99 × 100 (0.00 × 100) −0.58
48 3.30 × 100 (2.18 × 10−1) −0.54
72 2.98 × 100 (2.18 × 100) −0.59
144 no data (nd) nd
MS2 coliphage PFU/coupon (SD)
0 3.92 × 108 (4.20 × 108) ---
4 3.08 × 108 (2.68 × 108) −0.11
12 2.09 × 108 (1.67 × 108) −0.27
24 2.71 × 108 (3.34 × 108) −0.16
48 3.86 × 108 (5.19 × 108) −0.01
72 1.68 × 108 (1.32 × 108) −0.37
144 2.59 × 108 (7.21 × 107) −0.18
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